| CXHS2300088 | 维派那肽注射液 | PB-119 | Injection | Chemical Drugs(1) | New Drug Application | 2023-09-26 | | Hangzhou Ausia Biological Technology Company Ltd;Paige Biopharmaceutical (Hangzhou) Co Ltd | | | view |
| JYHB2200688 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs | Supplementary Application | 2022-12-31 | | AstraZeneca AB;Baxter Pharmaceutical Solutions LLC | | | view |
| JXHL0500069 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs(1.1) | Import Drug Application | 2005-04-21 | | Eli Lilly & Company | Certificate Issued | 2005-12-27 | view |
| CXHL2101223 | 聚乙二醇化艾塞那肽注射液 | PB-119 | Injection | Chemical Drugs(1) | New Drug Application | 2021-06-25 | | Paige Biopharmaceutical (Hangzhou) Co Ltd | | | view |
| CYHS2200215 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs(4) | Generic Drug | 2022-01-28 | | Chengdu Shengnuo Biopharm Co Ltd | | | view |
| CYHS2500772 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs(4) | Generic Drug | 2025-02-18 | | Chengdu Shengnuo Biopharm Co Ltd | | | view |
| CYHS2200469 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs(4) | Generic Drug | 2022-03-21 | | Hybio Pharmaceutical Co Ltd | | | view |
| JYHZ2300037 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs | License Renew | 2023-01-19 | | AstraZeneca AB;Baxter Pharmaceutical Solutions LLC;Astrazeneca Investment (China) Co Ltd | | | view |
| CYHS2200468 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs(4) | Generic Drug | 2022-03-21 | | Hybio Pharmaceutical Co Ltd | | | view |
| CYHS2402713 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs(4) | Generic Drug | 2024-08-20 | | Chengdu Shengnuo Biopharm Co Ltd | | | view |
| JYHZ2300036 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs | License Renew | 2023-01-19 | | AstraZeneca AB;Baxter Pharmaceutical Solutions LLC;Astrazeneca Investment (China) Co Ltd | | | view |
| CXHB2400043 | 聚乙二醇化艾塞那肽注射液 | PB-119 | Injection | Chemical Drugs(1) | Supplementary Application | 2024-02-19 | | Paige Biopharmaceutical (Hangzhou) Co Ltd | | | view |
| JYHB2200687 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs | Supplementary Application | 2022-12-31 | | AstraZeneca AB;Baxter Pharmaceutical Solutions LLC | | | view |
| JXHL0700307 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs(3.1) | Import Drug Application | 2007-11-06 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | Certificate Issued | 2009-05-20 | view |
| JXHL0900098 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs | Import Drug Application | 2009-04-09 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | Certificate Issued | 2010-02-09 | view |
| JXHL0900099 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs | Import Drug Application | 2009-03-31 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | Certificate Issued | 2010-02-09 | view |
| JYHB0901038 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs | Supplementary Application | 2009-12-02 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV;Baxter Pharmaceutical Solutions LLC | Certificate Issued | 2010-04-19 | view |
| JYHB0901037 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs | Supplementary Application | 2009-12-02 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV;Baxter Pharmaceutical Solutions LLC | Certificate Issued | 2010-04-19 | view |
| JXHL0700304 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs(3.1) | Import Drug Application | 2007-11-06 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | Certificate Issued | 2009-05-20 | view |
| CXHR0800072 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs | State Standards | 2008-11-19 | 内蒙古科诺医药开发有限公司 | Inner Mongolia Kenuo Pharmaceutical Development Co Ltd | Certificate Issued | 2010-06-08 | view |
